P&G Hygiene and Health Care: Ad spends down 8% in Q3 FY26

Procter & Gamble Hygiene and Health Care Ltd. reported marginal revenue growth and improved profitability for the quarter ended December 31, 2025 (Q3 FY26), supported by operational efficiencies and a favourable product price-mix.

The company recorded sales of ₹1,262 crore during the quarter, reflecting a 1% increase year-on-year. Total revenue stood at ₹1,274 crore in Q3 FY26, compared with ₹1,257 crore in the corresponding quarter of the previous fiscal.

Profit after tax (PAT) for the quarter rose 12% year-on-year to ₹301 crore, up from ₹268 crore in Q3 FY25.

Advertising and promotional expenditure declined during the quarter to ₹145 crore from ₹158 crore a year earlier, marking a reduction of approximately 8%. For the nine-month period ended December 31, 2025, advertising spends fell to ₹390 crore from ₹485 crore in the same period last year, a decrease of nearly 20%.

For the nine-month period of FY26, the company reported total revenue of ₹3,379 crore, compared with ₹3,340 crore in the corresponding period of the previous fiscal.

Commenting on the performance, Kumar Venkatasubramanian, Managing Director, Procter & Gamble Hygiene and Health Care Ltd., said the company continued to invest in consumer-focused initiatives, resulting in stable performance. He added that the company remains focused on its integrated growth strategy, which includes a concentrated product portfolio, emphasis on product performance, productivity improvements, and organisational agility.

The company’s profit for Q3 FY26 stood at ₹301 crore, reflecting improved profitability despite relatively modest topline growth.

The board has declared an interim dividend of ₹195 per equity share for FY2025-26, which includes a one-time special dividend of ₹25 per equity share.